Unclaimed Scholar Profile
Are you François Venter? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at University of the WitwatersrandASIDASID-1070-7952-0186 orcid.org/0000-0002-4157-732X
François Venter
University of the Witwatersrand•South Africa
Faculty researcher at University of the Witwatersrand (ZA), specializing in Physical Sciences & Engineering. [Discipline: Physical Sciences & Engineering] [Scholar Type: Policy & Economics Specialist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#HIV/AIDS Research and Interventions#HIV/AIDS drug development and treatment#HIV-related health complications and treatments#HIV Research and Treatment
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 10,879 | 5,222 |
| h-index | 55 | 41 |
| i10-index | 201 | 141 |
Annual Citation Growth
Verified Citations / Year0
2020522
2021+40%731
2022+29%940
2023+33%1.3k
2024-8%1.1k
2025-45%627
2026Scholarship Distribution & Proportions410 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (8,921) • 18% Global Research Impact (1,958)
410 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (410)
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
Published in New England Journal of Medicine•2019
DOI: 10.1056/nejmoa1902824 Verified Peer-Reviewed
Defining success with HIV pre-exposure prophylaxis
Published in AIDS•2015
DOI: 10.1097/qad.0000000000000647 Verified Peer-Reviewed
Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options
Published in AIDS Research and Therapy•2007
DOI: 10.1186/1742-6405-4-9 Verified Peer-Reviewed
Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study
Published in AIDS•2008
DOI: 10.1097/qad.0b013e3282f4a607 Verified Peer-Reviewed
Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial
Published in The Lancet HIV•2020
DOI: 10.1016/s2352-3018(20)30241-1 Verified Peer-Reviewed
Showing 1 – 5 of 410 publications
1 / 82